As we approved, through binding with GSK-3β protein, TRIM47 can enhance ADAR protein stability and ubiquitination so that TRIM47 endorses ADAR-mediated promotion of tumor migration and survival capability. The gene discussed is TRIM47; the disease is neoplasm.